Astrocyte Ca2+ signaling is facilitated in Scn1a+/- mouse model of Dravet syndrome

Biochem Biophys Res Commun. 2023 Feb 5:643:169-174. doi: 10.1016/j.bbrc.2022.12.084. Epub 2023 Jan 1.

Abstract

Dravet syndrome (DS) is an infantile-onset epileptic encephalopathy. More than 80% of DS patients have a heterozygous mutation in SCN1A, which encodes a subunit of the voltage-gated sodium channel, Nav1.1, in neurons. The roles played by astrocytes, the most abundant glial cell type in the brain, have been investigated in the pathogenesis of epilepsy; however, the specific involvement of astrocytes in DS has not been clarified. In this study, we evaluated Ca2+ signaling in astrocytes using genetically modified mice that have a loss-of-function mutation in Scn1a. We found that the slope of spontaneous Ca2+ spiking was increased without a change in amplitude in Scn1a+/- astrocytes. In addition, ATP-induced transient Ca2+ influx and the slope of Ca2+ spiking were also increased in Scn1a+/- astrocytes. These data indicate that perturbed Ca2+ dynamics in astrocytes may be involved in the pathogenesis of DS.

Keywords: Astrocyte; Ca(2+) spiking; Dravet syndrome; Epilepsy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Calcium Signaling
  • Epilepsies, Myoclonic* / genetics
  • Epilepsy*
  • Mice
  • NAV1.1 Voltage-Gated Sodium Channel / genetics
  • NAV1.1 Voltage-Gated Sodium Channel / metabolism
  • Neurons / metabolism

Substances

  • NAV1.1 Voltage-Gated Sodium Channel
  • Scn1a protein, mouse